NSN 6505-01-656-4670, (6505016564670) - Fentanyl Transdermal System Parts List
Fentanyl Transdermal System parts under NSN 6505-01-656-4670 manufactured by Mylan Pharmaceuticals Inc. All NSN items provided by NSN Parts Hub are compliant with fit, form, and functionality according to parameters set by the DLA. With over 3 billion new and obsolete parts in our searchable database, you can find your required part number of NSN 6505-01-656-4670 with ease when you use NSN Parts Hub as your purchasing partner. We maintain an unmatched supply-chain network with trusted MFRs and verified PMAs and are the only distributor with a No China Sourcing pledge. Do you require part numbers other than NDC00378-9126-98? Related NSN parts are listed below for your convenience.
Would you like a quote for NSN 6505-01-656-4670 Parts?
Simply submit an Instant RFQ for needed parts.
Alternative NSN: 6505016564670 |
Item Name: Fentanyl Transdermal System |
NIIN: 016564670 |
NCB Code: USA (01) |
Manufacturers: Mylan Pharmaceuticals Inc |
Part No | Manufacturer | Item Name | QTY | RFQ |
---|---|---|---|---|
NDC00378-9126-98 | mylan pharmaceuticals inc | fentanyl transdermal system | Avl | RFQ |
Characteristics Data of NSN 6505016564670
MRC | Criteria | Characteristic |
---|---|---|
CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | DURAGESIC-62.5 (FENTANYL TRANSDERMAL SYSTEM) 62.5MCG/HR, 5S |
FEAT | SPECIAL FEATURES | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 62.5 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (62.5 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH; STORE UP TO 20 C TO 25 C (68 F TO 77 F); STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
CRYC | CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE II |
CSLZ | USUAL DOSE | 62.5 MCG/HR |
6505-01-656-4670, 6505016564670 Search Related NSN Catalog
Recently Viewed Parts
Top National Stock Numbers
5306013334523 |
7490013953355 |
6140014469498 |
7025015900737 |
3130015369045 |
4730009541281 |
6240001557836 |
5965016488042 |
5330012852788 |
7210000527327 |